Abstract
This case-control study examines the association between receipt of the bradykinin 2 (B2) receptor antagonist icatibant and improved oxygenation in patients with coronavirus disease 2019 (COVID-19).
MeSH terms
-
Adult
-
Aged
-
Betacoronavirus
-
Bradykinin / analogs & derivatives*
-
Bradykinin / metabolism*
-
Bradykinin / therapeutic use
-
Bradykinin B2 Receptor Antagonists / therapeutic use*
-
COVID-19
-
COVID-19 Drug Treatment
-
Coronavirus Infections / drug therapy*
-
Coronavirus Infections / metabolism
-
Coronavirus Infections / virology
-
Female
-
Humans
-
Male
-
Middle Aged
-
Oxygen / blood
-
Pandemics
-
Pneumonia, Viral / drug therapy*
-
Pneumonia, Viral / metabolism
-
Pneumonia, Viral / virology
-
Receptor, Bradykinin B2 / metabolism*
-
SARS-CoV-2
Substances
-
Bradykinin B2 Receptor Antagonists
-
Receptor, Bradykinin B2
-
icatibant
-
Oxygen
-
Bradykinin